Regulus Therapeutics (NASDAQ:RGLS)

CAPS Rating: 1 out of 5

Results 1 - 3 of 3

Recs

0
Member Avatar pchop12316 (37.84) Submitted: 1/29/2015 11:58:50 AM : Outperform Start Price: $18.08 RGLS Score: +6.27

very promising

Recs

0
Member Avatar usubanas (99.73) Submitted: 10/23/2014 1:22:41 PM : Underperform Start Price: $14.01 RGLS Score: -34.61

HCV results not that great to justify a 600M mc.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:56:09 PM : Underperform Start Price: $9.51 RGLS Score: -81.61

Short. Biotech. High P/S ratio.

Results 1 - 3 of 3

Featured Broker Partners


Advertisement